The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into r...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1afbed199e54f1a8ad543881896922e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f1afbed199e54f1a8ad543881896922e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f1afbed199e54f1a8ad543881896922e2021-11-25T16:29:46ZThe Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases10.3390/antiox101118452076-3921https://doaj.org/article/f1afbed199e54f1a8ad543881896922e2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1845https://doaj.org/toc/2076-3921The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into routines in many laboratories, but the most valuable scientific contribution was the “waking up” of the gut microbiota. Disturbances in the gut microbiota, such as an imbalance in the beneficial/pathogenic effects and a decrease in diversity, can result in the passage of undesired chemicals and cells to the systemic circulation. Recently, the potential effect of probiotics on restoring/preserving the microbiota was also evaluated regarding important metabolite and vitamin production, pathogen exclusion, immune system maturation, and intestinal mucosal barrier integrity. Therefore, the focus of the present review is to discuss the available data and conclude what has been accomplished over the past two decades. This perspective fosters program development of the next steps that are necessary to obtain confirmation through clinical trials on the magnitude of the effects of kefir in large samples.Thiago M. C. PereiraLarissa Z. CôcoAlyne M. M. TonSilvana S. MeyrellesManuel Campos-ToimilBianca P. CampagnaroElisardo C. VasquezMDPI AGarticleoxidative stressinflammationneurodegenerative diseaseskefirchronic focal encephalitisangiotensin IITherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1845, p 1845 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
oxidative stress inflammation neurodegenerative diseases kefir chronic focal encephalitis angiotensin II Therapeutics. Pharmacology RM1-950 |
spellingShingle |
oxidative stress inflammation neurodegenerative diseases kefir chronic focal encephalitis angiotensin II Therapeutics. Pharmacology RM1-950 Thiago M. C. Pereira Larissa Z. Côco Alyne M. M. Ton Silvana S. Meyrelles Manuel Campos-Toimil Bianca P. Campagnaro Elisardo C. Vasquez The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
description |
The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into routines in many laboratories, but the most valuable scientific contribution was the “waking up” of the gut microbiota. Disturbances in the gut microbiota, such as an imbalance in the beneficial/pathogenic effects and a decrease in diversity, can result in the passage of undesired chemicals and cells to the systemic circulation. Recently, the potential effect of probiotics on restoring/preserving the microbiota was also evaluated regarding important metabolite and vitamin production, pathogen exclusion, immune system maturation, and intestinal mucosal barrier integrity. Therefore, the focus of the present review is to discuss the available data and conclude what has been accomplished over the past two decades. This perspective fosters program development of the next steps that are necessary to obtain confirmation through clinical trials on the magnitude of the effects of kefir in large samples. |
format |
article |
author |
Thiago M. C. Pereira Larissa Z. Côco Alyne M. M. Ton Silvana S. Meyrelles Manuel Campos-Toimil Bianca P. Campagnaro Elisardo C. Vasquez |
author_facet |
Thiago M. C. Pereira Larissa Z. Côco Alyne M. M. Ton Silvana S. Meyrelles Manuel Campos-Toimil Bianca P. Campagnaro Elisardo C. Vasquez |
author_sort |
Thiago M. C. Pereira |
title |
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
title_short |
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
title_full |
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
title_fullStr |
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
title_full_unstemmed |
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases |
title_sort |
emerging scenario of the gut–brain axis: the therapeutic actions of the new actor kefir against neurodegenerative diseases |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/f1afbed199e54f1a8ad543881896922e |
work_keys_str_mv |
AT thiagomcpereira theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT larissazcoco theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT alynemmton theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT silvanasmeyrelles theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT manuelcampostoimil theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT biancapcampagnaro theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT elisardocvasquez theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT thiagomcpereira emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT larissazcoco emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT alynemmton emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT silvanasmeyrelles emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT manuelcampostoimil emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT biancapcampagnaro emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases AT elisardocvasquez emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases |
_version_ |
1718413175028711424 |